维普中文期刊产品整合服务
40篇 您的检索式:作者名="PAPAY J"
    题名 作者 年代 出处 被引量
1Effect of melatonin on the severity of L-arginine-induced experimental acute pancreatitis in rats显示文摘瞄准:决定 melatonin 预告的处理的效果并且在 L 精氨酸(L-Arg ) 的严厉上处理以后在老鼠的导致的试验性的胰腺炎。方法:男 Wistar 老鼠(25 ) 被划分成五个组。那些在 1h 的间隔在组 A 收到了 3.2g/kg 体重 L-Arg i.p 的二注射。在组麻省,老鼠与 50 mg/kg 体重 melatonin i.p 被对待在 L-Arg 管理以前的 30 min。在组 AM,在 L-Arg 被给以后,老鼠收到了 melatonin 1h 的一样的剂量。在组 M, melatonin 的单次量是以前描述了被管理。在组 C,对照动物收到了生理盐水注射 i.p 所有老鼠被给在第二 L-Arg 注射以后的 24 h。结果:引起严重引起坏死胰腺炎的 L-Arg 管理在浆液淀粉酶水平,胰腺的重量 / 身体重量比率(pw/bw ) ,胰腺的 IL-6 内容和 myeloperoxidase 由重要举起证实了活动,相对控制值。浆液淀粉酶水平的举起显著地在与仅仅与 L-Arg 注射的老鼠相比给 melatonin 追随者 L-Arg 的老鼠被减少。胰腺的抗氧化剂酶(Cu/Zn-superoxide 歧化酶(Cu/Zn-SOD ) 和过氧化氢酶(猫)) 的活动显著地被增加在胰腺炎以后的 24 h 感应。显著地在 L-Arg 之前给的 Melatonin 在独自与 L-Arg 对待的老鼠相对那减少了胰腺的猫活动。在肝, L-Arg 显著地每氧化水平,和谷胱甘肽过氧化物酶和 Cu/Zn-SOD 活动增加了类脂化合物,而 Mn 草皮活动作为与控制老鼠相比被减少。Melatonin 预告的处理阻止了这些变化。结论:Melatonin 是能在尖锐胰腺炎期间抵抗一些 L-Arg-induced 变化的一种抗氧化剂,并且可能因此在有尖锐引起坏死胰腺炎的病人的支持的治疗有用。Annamaria Szabolcs Russel J Reiter Tamas Letoha Peter Hegyi Gabor Papai Ilona Varga Katalin Jarmay Jozsef Kaszaki Reka Sari Zoltan Rakonczay Jr Janos Lonovics Tamas Takacs 2006World Journal of Gastroenterology2006,12,2:13
2Childhood dermatofibrosarcoma proluberans:role of preoperative imaging显示文摘Thornton SL Reid J Papay FA 0,,:1
3Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2) 显示文摘Pritchard KI Rolski J Papai Z 2010Breast Cancer Res Treat2010,123,2:1
4Epidermal growth factor recep- tor (EGFR) high gene copy number and activating mutations in are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry显示文摘Pinter F Papay J Almasi A 2008J Mol Di-agn2008,10,2:1
5Association of simvastatin and hyperlipidemia with periodontalstatus and bone metabolism markers 显示文摘MAGAN FERNANDEZ A PAPAY RAMIREZ L TOMAS J etal 2014J Periodontol2014,85,10:1
6In vitrocytotoxicities of ionic liquids :Effect of cation rings,functionalgroups ,and anions 显示文摘Kumar R A Papai'conomou N Lee J M ei al 2009Environmental Toxicology2009,24,4:1
7The effect of lentinan on the metastasis of Lewis lung carcinoma显示文摘Lapis K Papay J Paku S 1989Int J Immunother1989,11,5:1
8Immunophenotypic profiling ofnonsmall cell lung cancer progression using the tissue microarray ap-proach显示文摘Papay J Krenacs T Moldvay J 2007Appl Immunohistochem Mol Morphol2007,15,1:1
9Epidermal growth factor receptor(EGFR)high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry显示文摘Pinter F Papay J Almasi A 2008J Mol Diagn2008,10,2:1
10Epidermal growth factor receptor(EGFR) high gene copy number and activating mutations in lung ad-enocarcinomas are not consistently accompanied by positivity forEGFR protein by standard immunohistochemistry 显示文摘Pinter F Papay J Almasi A 2008J Mol Diagn2008,10,2:1
11Childhood dermatofibro- sarcoma protuberans:role of preoperative imaging显示文摘Thornton S L Reid J Papay F A 2005J Am Acad Dermatol2005,53,1:1
12Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2) 显示文摘Pritchard KI Rolski J Papai Z 2010Breast Cancer Cancer Res Treat2010,123,2:1
13Treatment of recurrent cerebrospinal fluid rhinorrhea with a free vascularized omental flap:a case report显示文摘NORMINGTON E Y PAPAY F A YETMAN R J 1996Plast Reconstr Surg1996,98,:1
14Open-label,multicenter,randomizad,phase Ⅲ study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer显示文摘Eckordt JR von Pawel J Papai Z 2006J Clin Oncol2006,24,13:1
15Immunophenotypic pro- filing of non small cell lung cancer progression using the tissue microarray app roach显示文摘Papay J Krenacs T Moldvay J 2007Appl Immunohistochem Mol Morphol2007,15,1:1
16Different Tests, Different Answers: The Stability of Teacher Value - Added Estimates Across Outcome Measures 显示文摘Papay J P 2010American Educational Research Journal2010,,:1
17Monitoring liver safetyin drug development:the GSK experience显示文摘Hunt C M Papay J I Edwards R I 2007Regul ToxicolPharmacol2007,49,2:1
18Results of a phaseII study comparing three dosing regimens of fulvestrantin postmenopausal women with advanced breast cancer(FINDER2)显示文摘Pritchard KI Rolski J Papai Z 2010Breast Cancer Res Treat2010,123,2:1
19Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenoearcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry显示文摘Pinter F Papay J Almasi A 2008J Mol Diagan2008,10,2:1
20Open-label,multicenter,randomized,phase Ⅲ study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapynaive patients with extensive-disease small-cell lung cancer显示文摘Eckardt JR von Pawel J Papai Z 2006J Clin Oncol2006,24,13:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费